Viewing StudyNCT01589094



Ignite Creation Date: 2024-05-06 @ 12:29 AM
Last Modification Date: 2024-10-26 @ 10:50 AM
Study NCT ID: NCT01589094
Status: COMPLETED
Last Update Posted: 2019-10-02
First Post: 2012-04-27

Brief Title: Neoadjuvant Dose Dense Gemcitabine and Cisplatin DD GC In Patients With Muscle-Invasive Bladder Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Organization: Memorial Sloan Kettering Cancer Center

Conditions & Keywords Data

Conditions:
Name
Bladder Cancer
Keywords:
Name View
CISPLATIN View
GEMCITABINE View
GM-CSF View
radical cystectomy View
12-071 View